Published in Drug Metab Dispos on July 03, 1990
Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin. Comp Med (2008) 0.88
Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse. Drug Metab Dispos (2011) 0.87
Biotransformations utilizing β-oxidation cycle reactions in the synthesis of natural compounds and medicines. Int J Mol Sci (2012) 0.81
Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects. Eur J Clin Pharmacol (2012) 0.77
A Simple Protein Precipitation-based Simultaneous Quantification of Lovastatin and Its Active Metabolite Lovastatin Acid in Human Plasma by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry using Polarity Switching. J Chromatogr Sep Tech (2015) 0.75
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
A new class of angiotensin-converting enzyme inhibitors. Nature (1980) 3.03
Health status of the New York City prison population. Med Care (1977) 2.57
Enalapril maleate and a lysine analogue (MK-521): disposition in man. Br J Clin Pharmacol (1982) 2.49
Sarcoplasmic reticulum. 3. The role of phospholipids in the adenosine triphosphatase activity and Ca++ transport. J Biol Chem (1968) 1.97
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Br J Clin Pharmacol (1982) 1.95
The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos (1982) 1.79
Effect of alcohol and various diseases on leukocyte mobilization, phagocytosis and intracellular bacterial killing. N Engl J Med (1970) 1.75
The normal motor unit in man. A single fibre EMG multielectrode investigation. J Neurol Sci (1976) 1.69
Alpha-isopropylmalate synthase from yeast: purification, kinetic studies, and effect of ligands on stability. J Bacteriol (1972) 1.66
Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am J Med (1990) 1.59
High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res (1998) 1.56
Single fibre electromyography in various processes affecting the anterior horn cell. J Neurol Sci (1975) 1.52
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med (1993) 1.50
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem (1999) 1.47
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. J Pharmacol Exp Ther (1981) 1.44
Interferon effects on the growth and division of human fibroblasts. Exp Cell Res (1979) 1.40
Myopathy in Whipple's disease. Gut (1977) 1.31
Sarcoplasmic reticulum. X. The protein composition of sarcoplasmic reticulum membranes. Arch Biochem Biophys (1971) 1.29
Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med (1989) 1.27
Longitudinal fibre splitting in neurogenic muscular disorders--its relation to the pathogenesis of "myopathic" change. Brain (1976) 1.26
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation. Biochemistry (1994) 1.22
Correlates of suffering in amyotrophic lateral sclerosis. Neurology (1999) 1.21
Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine. Drug Metab Dispos (2000) 1.18
Implications of longitudinal muscle fibre splitting in neurogenic and myopathic disorders. J Neurol Neurosurg Psychiatry (1977) 1.17
Scapuloperoneal atrophy with sensory involvement: Davidenkow's syndrome. J Neurol Neurosurg Psychiatry (1975) 1.17
Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure. Biochemistry (1995) 1.16
Evidence of subnormal function of association cortex in presenile dementia. Neurology (1975) 1.15
Effect of experimental diabetes on elimination kinetics of diflunisal in rats. Drug Metab Dispos (1989) 1.14
Isolated petit-mal status presenting de novo in middle age. Lancet (1971) 1.14
Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes. Arch Biochem Biophys (1991) 1.14
Development of the Belfast orthopaedic information system. Health Serv Manage (1989) 1.13
Epithienamycins. II. Isolation and structure assignment. J Antibiot (Tokyo) (1981) 1.13
Carpal tunnel syndrome: which finger should be tested? An analysis of sensory conduction in digital branches of the median nerve. Muscle Nerve (1990) 1.12
Pattern of involvement in the cervical segments in the early stage of motor neurone disease: a single fibre EMG study. Acta Neurol Scand (1982) 1.09
Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains. Proc Natl Acad Sci U S A (1987) 1.08
Adrenerigic agents. 7.1 Synthesis and beta-adrenergic agonist activity of several 2-pyridylethanolamines. J Med Chem (1977) 1.08
Safety factor in single human motor end-plates studied in vivo with single fibre electromyography. J Neurol Neurosurg Psychiatry (1975) 1.07
Single-muscle-fiber recording of the jitter phenomenon in patients with myasthenia gravis and in members of their families. Ann N Y Acad Sci (1976) 1.07
Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg (1979) 1.06
Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man. Drug Metab Rev (1983) 1.04
Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy. Brain (1983) 1.04
Adult onset acid maltase deficiency. Distribution and progression of clinical and pathological abnormality in a family. J Neurol Sci (1985) 1.04
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase. Drug Metab Dispos (1990) 1.03
Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatogr A (1996) 1.02
Isopentenoid synthesis in isolated embryonic Drosophila cells. Farnesol catabolism and omega-oxidation. J Biol Chem (1988) 1.02
Spontaneous rapid resolution of an epidural hematoma associated with an overlying skull fracture and subgaleal hematoma in a 17-month-old child. Pediatr Neurosurg (1997) 1.02
The physiological disposition of lovastatin. Drug Metab Dispos (1989) 1.00
Regional curare for the reduction of the safety factor in human motor end-plates studied with single fibre electromyography. J Neurol Neurosurg Psychiatry (1975) 1.00
Role of oleate in the regulation of "neutral" rabbit liver fructose 1,6-diphosphatase activity. J Biol Chem (1973) 0.99
Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J Clin Pharmacol (1992) 0.99
The occurrence and evolution in the EEG of a lateralized periodic phenomenon. Brain (1973) 0.99
Malaria myositis. J Neurol Neurosurg Psychiatry (1993) 0.98
HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J Pharmacol Exp Ther (1991) 0.98
Pathological stimulus-related slow wave arousal responses in the EEG. Acta Neurol Scand (1978) 0.97
Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats. Drug Metab Dispos (1988) 0.97
Transcrusal approach to the petroclival region with hearing preservation. Technical note and illustrative cases. J Neurosurg (2001) 0.96
Rate of spinal trabecular bone loss in normal perimenopausal women: CT measurement. Radiology (1986) 0.96
Classification and quantification of the petrosal approach to the petroclival region. J Neurosurg (2000) 0.96
Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica (1985) 0.95
A mental health center's response to racial crisis in an urban high school. Psychiatry (1969) 0.95
Total joint replacement: implication of cancelled operations for hospital costs and waiting list management. Qual Health Care (1992) 0.94
A Phase I study of LGD1069 in adults with advanced cancer. Clin Cancer Res (1999) 0.94
Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors. Drug Metab Dispos (2001) 0.94
Benign postinfection polymyositis. Br Med J (1978) 0.94
Phosphorus-containing inhibitors of angiotensin-converting enzyme. Proc Natl Acad Sci U S A (1982) 0.93
Novel renin inhibitors containing the amino acid statine. Nature (1983) 0.93
Identification of cordycepin, a metabolite of Cordyceps militaris, as 3'-deoxyadenosine. Biochem Biophys Res Commun (1964) 0.92
Inhibitors of glycolic acid oxidase. 4-Substituted 3-hydroxy-1H-pyrrole-2,5-dione derivatives. J Med Chem (1983) 0.92
Slowed nerve conduction with wrist flexion in carpal tunnel syndrome. Ann Neurol (1980) 0.91
Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs. Proc Natl Acad Sci U S A (1989) 0.91
Vitamin D deficiency rickets. Reports of its demise are exaggerated. Clin Pediatr (Phila) (1994) 0.91
Juvenile-onset bulbospinal muscular atrophy with deafness: Vialetta-van Laere syndrome or Madras-type motor neuron disease? J Neurol (1987) 0.91
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin. J Med Chem (1986) 0.90
Recurrent transient ischemic attacks secondary to an embolizing saccular middle cerebral artery aneurysm. Case report. J Neurosurg (1979) 0.90
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. J Med Chem (2000) 0.89
Kearns-Sayre syndrome, hypoparathyroidism, and basal ganglia calcification. J Neurol Neurosurg Psychiatry (1986) 0.89
THE URINARY/FECAL COPROPORPHYRIN RATIO IN LIVER DISEASE. J Clin Invest (1941) 0.89
The reaction of PGA1 with sulfhydryl groups; a component in the binding of A-type prostaglandins to proteins. Prostaglandins (1975) 0.88
Enzymatic phosphorylation of the antiherpetic agent 9-[(2,3-dihydroxy-1-propoxy)methyl]guanine. J Med Chem (1986) 0.88
Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci U S A (1991) 0.88
Urinary excretion kinetics of famotidine in rats. Drug Metab Dispos (1987) 0.88
A gene (pks2) encoding a putative 6-methylsalicylic acid synthase from Glarea lozoyensis. Mol Genet Genomics (2005) 0.88
Jitter correction: a computer algorithm for reduction of the velocity recovery function artifact. Muscle Nerve (1988) 0.88
Single fibre electromyographic studies in myasthenia gravis with repetitive nerve stimulation. J Neurol Neurosurg Psychiatry (1975) 0.87
Disturbed neuromuscular transmission in viral infection. N Engl J Med (1977) 0.87
Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas. Euro Surveill (2015) 0.87
Pattern of segmental motor involvement in syringomyelia: a single fibre EMG study. J Neurol Neurosurg Psychiatry (1980) 0.87
Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes. Drug Metab Dispos (1998) 0.86
Myasthenia gravis with features of the myasthenic syndrome. An investigation with electrophysiologic methods including single-fiber electromyography. Neurology (1975) 0.86
Correlation of single fibre EMG and muscle histochrmistry using an open biopsy recording technique. J Neurol Sci (1977) 0.86
Structure-function studies on the cyclic peptide MT-II, lactam derivative of alpha-melanotropin. Peptides (1999) 0.86
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans. Drug Metab Dispos (2000) 0.86
Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry. Biol Mass Spectrom (1993) 0.86
Microbial conversion of avermectins by Saccharopolyspora erythraea: glycosylation at C-4' and C-4''. Antimicrob Agents Chemother (1993) 0.86